المؤلفون: Holman, Rury R., Coleman, Roth L., Chan, Juliana C. N., Chiasson, Jean-Louis, Feng, Huimei, Ge, Junbo, Gerstein, Hertzel C., Gray, Richard, Huo, Yong, Lang, Zhihui, McMurray, John, Ryden, Lars, Schroeder, Stefan, Sun, Yihong, Theodorakis, Michael J., Tendera, Michal, Tucker, Lynne, Tuomilehto, Jaakko, Wei, Yidong, Yang, Wenying, Wang, Duolao, Hu, Dayi, Pan, Changyu

المساهمون: Holman, RR (reprint author), Churchill Hosp, Diabet Trials Unit, Oxford OX3 7LJ, England., Univ Oxford, Diabet Trials Unit, Oxford, England., Univ Oxford, MRC Populat Hlth Res Unit, Oxford, England., Chinese Univ Hong Kong, Prince Wales Hosp Shatin, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China., Univ Montreal, Ctr Rech, Ctr Hosp, Dept Med, Montreal, PQ, Canada., Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China., McMaster Univ, Dept Med & Populat, Hlth Res Inst, Hamilton, ON, Canada., Hamilton Hlth Sci, Hamilton, ON, Canada., Peking Univ, Hosp 1, Dept Cardiol, Beijing, Peoples R China., Bayer Healthcare Co Ltd, Beijing, Peoples R China., Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland., Karolinska Inst, Dept Med K2, Stockholm, Sweden., Bayer AG, Pharma Div, Berlin, Germany., China Japan Friendship Hosp, Beijing, Peoples R China., Med Univ Silesia, Sch Med Katowice, Dept Cardiol & Struct Heart Dis, Katowice, Poland., Dasman Diabet Inst, Dasman, Kuwait., Danube Univ Krems, Dept Neurosci & Prevent Med, Krems, Austria., Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland., King Abdulaziz Univ, Jeddah, Saudi Arabia., Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Shanghai, Peoples R China., Univ Liverpool Liverpool Sch Trop Med, Trop Clin Trials Unit, Liverpool, Merseyside, England., Peking Univ, Peoples Hosp, Beijing, Peoples R China., Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China., Churchill Hosp, Diabet Trials Unit, Oxford OX3 7LJ, England.

المصدر: SCI

مصطلحات موضوعية: GLUCAGON-LIKE PEPTIDE-1, MYOCARDIAL-INFARCTION, LONG-TERM, FOLLOW-UP, PREVENTION, NIDDM, RISK, HYPERTENSION, PROGRESSION, FAILURE

العلاقة: LANCET DIABETES & ENDOCRINOLOGY. 2017, 5(11), 877-886.; 1938594; http://hdl.handle.net/20.500.11897/484539Test; WOS:000413782300020

الإتاحة: https://doi.org/20.500.11897/484539Test
https://doi.org/10.1016/S2213-8587Test(17)30309-1
https://hdl.handle.net/20.500.11897/484539Test

المؤلفون: Holman, Rury R., Bethel, Mary A., Chan, Juliana C. N., Chiasson, Jean-Louis, Doran, Zoe, Ge, Junbo, Gerstein, Hertzel, Huo, Yong, McMurray, John J., Ryden, Lars, Liyanage, Winitha, Schroeder, Stefan, Tendera, Michal, Theodorakis, Michael J., Tuomilehto, Jaakko, Yang, Wenying, Hu, Dayi, Pan, Changyu

المساهمون: Holman, RR (reprint author), Churchill Hosp, OCDEM, Diabet Trials Unit, Oxford 0X3 7IJ, England., Univ Oxford, Diabet Trials Unit, Oxford, England., Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China., Univ Montreal, Dept Med, CRCHUM, Montreal, PQ H3C 3J7, Canada., Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China., McMaster Univ, Dept Med, Hamilton, ON, Canada., McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada., Hamilton Hlth Sci, Hamilton, ON, Canada., Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China., Univ Glasgow, Inst Cardiovasc Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland., Karolinska Univ Hosp Solna, Cardiol Unit, Stockholm, Sweden., Bayer Pharma AG, Bayer Healthcare, Berlin, Germany., Med Univ Silesia, Div Cardiol 3, Katowice, Poland., Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria., Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland., King Abdulaziz Univ, Jeddah 21413, Saudi Arabia., China Japan Friendship Hosp, Beijing, Peoples R China., Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China., Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China., Churchill Hosp, OCDEM, Diabet Trials Unit, Oxford 0X3 7IJ, England.

المصدر: PubMed ; SCI

مصطلحات موضوعية: IMPAIRED GLUCOSE-TOLERANCE, TYPE-2 DIABETES-MELLITUS, OXIDATIVE STRESS, POSTCHALLENGE HYPERGLYCEMIA, POSTPRANDIAL HYPERGLYCEMIA, ENDOTHELIAL DYSFUNCTION, COAGULATION ACTIVATION, MYOCARDIAL-INFARCTION, PREVENTION PROGRAM, DISEASE

العلاقة: AMERICAN HEART JOURNAL.2014,168,(1),23-29.; 653329; http://hdl.handle.net/20.500.11897/189362Test; WOS:000338748800005

الإتاحة: https://doi.org/20.500.11897/189362Test
https://doi.org/10.1016/j.ahj.2014.03.021Test
https://hdl.handle.net/20.500.11897/189362Test

المؤلفون: Sun YiHong, Bethel, M. Angelyn, Holman, Rury R., Sourij, Harald, Harrison, Paul F., Tucker, Lynne, Kennedy, Irene, White, Sarah, Hill, Lucy, Oulhaj, Abderrahim, Coleman, Ruth, Hu, Dayi

المساهمون: Peking Univ, Peoples Hosp, Beijing, Peoples R China., Univ Oxford, Diabet Trials Unit, Oxford, England., John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England., Univ Birmingham, Sch Med, Sch Immun & Infect, Birmingham, W Midlands, England.

المصدر: SCI

العلاقة: HEART.2013,99,E249-E250.; 816075; http://hdl.handle.net/20.500.11897/308169Test; WOS:000331272900702

الإتاحة: https://doi.org/20.500.11897/308169Test
https://doi.org/10.1136/heartjnl-2013-304613.704Test
https://hdl.handle.net/20.500.11897/308169Test